Other larger retrospective study where majority of resected NSCLC specimens were stage I–IIIA (785/800), reported PD-L1 TPS <1%, 1% to 49% and ≥50% was in 75.3%, 17.5%, and 7.2% cases [44]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.